You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Guselkumab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • Reference number: TA521
  • Published:  13 June 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information about guselkumab
  • 3 Committee discussion
  • 4 Implementation
  • 5 Appraisal committee members and NICE project team
  • 6 Update information

6 Update information

November 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on psoriasis: assessment and management. This does not affect the meaning or intent of the guidance.

ISBN: 978-1-4731-2972-6


Previous page 5 Appraisal committee members and NICE project team
Back to top